Jenine Ramruthan

Awareness of hereditary breast cancer and readiness for genetic testing among newly diagnosed patients with breast cancer in Nigeria: a multicentre study

Funmilola O. Wuraola, Jenine Ramruthan, Victoria L. Mango, Nneka Sunday-Nweke et autres

Abstract Background Germline BRCA1/2 pathogenic variants account for up to 11% of breast cancer (BC) cases in Nigeria, approximately twice the prevalence reported in high-income populations. However, access to hereditary cancer services remains limited and patient awareness is largely uncharacterized. Prior studies …

Nigéria, ca, us (code pays fourni par la source)

Development and evaluation of a BRCA1/2 education program for Nigerian healthcare providers

Funmilola Olanike Wuraola, Jenine Ramruthan, Emma Reel, Emily Thain et autres

Continued medical education is vital for cancer control in low-resource settings. A recent survey of healthcare providers (HCPs) in Nigeria identified lack of training programs as a major barrier to implementing breast cancer genetic testing. In response, we developed and evaluated an …

Nigéria, ca, in (code pays fourni par la source)

ASO Visual Abstract: Breast Cancer Surgery Wait Times and COVID-19—A Canadian Population-Based Analysis

Gary Ko, Qing Li, Ning Liu, Eitan Amir et autres

ca (code pays fourni par la source)

Breast Cancer Surgery Wait Times and COVID-19: A Canadian Population-Based Analysis

Gary Ko, Qing Li, Ning Liu, Eitan Amir et autres

BACKGROUND: During the COVID-19 pandemic, operating room restrictions led to triaging of breast cancer (BC) surgery. This study assessed the impact of the pandemic on wait times for BC surgery at a population level. METHODS: Patients diagnosed with BC between January 2018 …

ca (code pays fourni par la source)

Pilot Health Care Provider Education Program for BRCA1 / 2 Genetic Testing, Counseling, and Management in Nigeria

Funmilola Wuraola, Jenine Ramruthan, Emma Reel, Larissa Peck et autres

PURPOSE Breast cancer (BC) is a significant health challenge in Nigeria, exacerbated by early onset, advanced-stage diagnosis, and high prevalence of triple-negative tumors. Access to genetic testing and counseling is scarce, with minimal capacity for hereditary cancer services. Despite these barriers, there …

Nigéria, ca, us (code pays fourni par la source)

Abstract P4-02-02: Hospitalizations and emergency visits for Ontario breast cancer patients undergoing neoadjuvant chemotherapy with pembrolizumab: A population-based analysis

Gary T.C. Ko, Eitan Amir, Matthew Castelo, Andrea Covelli et autres

Abstract Background: Immunotherapy-containing chemotherapy regimens are increasingly used for the neoadjuvant treatment of triple negative breast cancer (BC). However, these regimens can be associated with immune-related adverse events, which may lead to increased hospitalizations and emergency department (ED) visits. The objective of …

Knowledge and perceptions of genetic testing for patients with breast cancer in Nigeria: a survey of healthcare providers

Funmilola Wuraola, Anna Dare, Jenine Ramruthan, Emma Reel et autres

BACKGROUND: The role of genetics in breast cancer management is becoming increasingly essential in sub-Saharan Africa (SSA). Harmonized Guidelines by the National Comprehensive Cancer Network (NCCN) for SSA outline the subset of patients requiring genetic testing for hereditary breast cancer as part …

Nigéria, ca (code pays fourni par la source)

The ACTION Study: Addressing global inequities in breast cancer genetic testing, counselling, and management among breast cancer patients in Nigeria - A Healthcare Provider Educational Program

Funmilola Wuraola, Jenine Ramruthan, Emma Reel, Carolyn L. Kerrigan et autres

Nigéria, ca (code pays fourni par la source)

Impact of the COVID-19 pandemic on breast cancer surgeries in a Canadian population

Gary Ko, Qing Li, Ning Liu, Eitan Amir et autres

PURPOSE: The COVID-19 pandemic significantly impacted breast cancer (BC) surgeries. Most studies showing reduced BC surgical volumes during the pandemic are from single institutions, few have described volume changes in different types of surgical procedures. This study aimed to assess the impact …

ca (code pays fourni par la source)

Feasibility of BRCA1 and BRCA2 testing among Nigerian women with breast cancer

Funmilola Wuraola, Jenine Ramruthan, Emma Reel, Andrea Covelli et autres

Nigéria, ca (code pays fourni par la source)

Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis

Halima Dawood, Nonhlanhla Yende‐Zuma, Upasna Singh, Mikaila C. Moodley et autres

INTRODUCTION: Hypertension is a leading risk factor for cardiovascular disease among people living with human immunodeficiency virus (PLWH). This study determined incidence and prevalence of hypertension among PLWH receiving antiretroviral therapy (ART). METHOD: We prospectively followed-up 642 HIV and tuberculosis (TB) co-infected …

Afrique du Sud (code pays fourni par la source)

A third-line antiretroviral therapy register to track patient clinical and virological outcomes

Kogieleum Naidoo, Jenine Ramruthan, M Reddy, R Lancaster

In 2021, South Africa (SA) had an estimated 7.8 million people living with HIV, of whom 5.6 million were receiving antiretroviral therapy (ART),[1] with 3.4 million on first-line ART, 145 000 on second-line ART (SLART) and >700 on third-line ART (TLART).

Afrique du Sud (code pays fourni par la source)